Stock Price & Analysis

Based on the analysis of ACT stock's current performance and market indicators, the stock is in a neutral zone with no strong buy or sell signal. It is recommended to hold or wait for further market clarity before making a decision.

The price prediction for ACT stock in 2025 is approximately $38, driven by the average analyst price target and moderate buy ratings. Analysts expect the stock to rise due to positive earnings and growth prospects.

The S1 support level for ACT Stock is $32.8 ,The R1 resistant level for ACT Stock is $34.52.

As of the end of day on 2025-03-14, the price of ACT Stock was $33.2.

The target price for ACT Stock according to analyst rating is 38.33, with the highest price target at 41.00 and the lowest at 36.00. Analysts have a Moderate Buy rating on ACT Stock overall.

The market cap of ACT is $5.0B.

Analysis and Insights

To determine if ACT is overvalued, we analyze its valuation metrics, technical indicators, and market context.

Valuation Analysis:

ACT's valuation metrics indicate it is not overvalued. The forward P/E ratio of 7.41 is relatively low, suggesting undervaluation compared to industry peers. The EV/EBITDA of 4.25 is moderate, and the P/S ratio of 2.21 aligns with industry standards. The P/B ratio of 0.99 indicates the stock is fairly valued relative to its book value.

Technical Analysis:

ACT's stock price is currently $33.11, near the lower end of its Fibonacci support levels (32.58 - 33.06). The RSI of 48.85 suggests the stock is not overbought, and the MACD indicates slight upward momentum. The stock is trading near its 20-day SMA but below the 50-day SMA, signaling a potential consolidation phase.

Market Context:

While there's no specific news on ACT, broader market trends show cautious sentiment with some stocks experiencing pullbacks. This could impact ACT, but without negative news, its fundamentals remain stable.

Conclusion:

ACT appears undervalued based on its low P/E, moderate EV/EBITDA, and neutral technical indicators. It may present a buying opportunity, especially if market sentiment improves.

Enact Holdings, Inc. is a private mortgage insurance company. The Company operates principally through its wholly owned subsidiary, Enact Mortgage Insurance Corporation. It is engaged in the business of writing and assuming residential mortgage guaranty insurance. The insurance protects lenders and investors against certain losses resulting from nonpayment of loans secured by mortgages, deeds of trust or other instruments constituting a first lien on residential real estate. It facilitates the sale of mortgages to the secondary market, including to private investors, as well as the Federal National Mortgage Association (Fannie Mae) and the Federal Home Loan Mortgage Corporation (Freddie Mac). It has a diverse customer base and maintains enduring relationships across the mortgage origination market, including with national banks, non-bank mortgage lenders, local mortgage bankers, community banks and credit unions.

The price prediction for ACT stock by 2030 is approximately $45 to $50. This forecast is based on current Fibonacci extension levels and analyst price targets, which suggest significant upside potential. The stock's technical indicators and recent buy ratings from analysts like Bank of America support this bullish outlook.

ACT has a total of 465 employees.